Medicare Enrolled

Dr. Bhaskara Madhira, MD

Hematology & Oncology · Abilene, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1957 ANTILLEY RD, Abilene, TX 79606
3256920188
In practice since 2008 (17 years)
NPI: 1689825861 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Madhira from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Madhira? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Madhira

Dr. Bhaskara Madhira is a hematology & oncology in Abilene, TX, with 17 years in practice. Based on federal Medicare data, Dr. Madhira performed 12,779 Medicare services across 1,596 unique beneficiaries.

Between the years covered by Open Payments, Dr. Madhira received a total of $776 from 15 pharmaceutical and/or device companies across 18 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Madhira is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 36% volume in TX$ $776 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,779
Medicare services
Top 36% in TX for hematology & oncology
1,596
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~752 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)8,160$0$5
Contrast dye for imaging (iodine-based)1,675$0$3
Blood draw (venipuncture)369$8$20
Complete blood count (CBC) with differential310$8$36
Dexamethasone injection (steroid)246$0$1
Comprehensive metabolic blood panel221$10$64
Office visit, established patient (30-39 min)200$92$368
Office visit, established patient (20-29 min)121$59$250
Hospital follow-up visit, moderate complexity91$62$227
Ferritin level test (iron stores)61$13$60
Albumin (protein) level60$5$28
Bilirubin level, total60$5$23
Calcium level, total60$5$30
Carbon dioxide (bicarbonate) level60$5$24
Blood chloride level60$5$25
Blood creatinine level60$5$31
Iron level test60$6$27
Iron binding capacity test60$9$35
Phosphatase (enzyme) level, alkaline60$5$27
Blood potassium level60$5$30
Total protein level, blood60$4$42
Liver enzyme (sgot), level60$5$33
Liver enzyme (sgpt), level60$5$28
Urea nitrogen level to assess kidney function, quantitative60$4$24
Office visit, established patient, complex (40-54 min)60$134$496
Microscopic examination for white blood cells with manual cell count47$4$22
Complete blood count (CBC), automated47$6$34
Lactate dehydrogenase (enzyme) level44$6$31
Administration of chemotherapy into vein, 1 hour or less42$101$707
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less33$22$157
Hospital follow-up visit, high complexity31$90$318
Initial hospital admission, high complexity30$133$655
New patient office visit (45-59 min)29$94$565
Hospital follow-up visit, low complexity29$42$142
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less20$49$313
Red blood count automated, with additional calculations17$5$26
Administration of additional new drug or substance into vein, 1 hour or less15$50$344
New patient office visit, complex (60-74 min)15$160$709
Carcinoembryonic antigen (cea) protein level14$19$99
Hospital discharge day management, 30 minutes or less12$63$220
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
64.3% high complexity
15.4% medium
20.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$776
Total received (2020-2024)
Avg $155/year across 5 years
Bottom 25% in TX for hematology & oncology
15
Companies
18
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$760 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15 (2.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$29
2023
$376
2022
$304
2021
$51
2020
$15

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$130
CTI BioPharma Corp.
$108
PharmaEssentia USA Corporation
$97
Alexion Pharmaceuticals, Inc.
$85
Janssen Biotech, Inc.
$82
Gilead Sciences, Inc.
$79
Novartis Pharmaceuticals Corporation
$36
Geron Corporation
$29
PFIZER INC.
$24
GENZYME CORPORATION
$22
Sobi, Inc
$20
TerSera Therapeutics LLC
$18
E.R. Squibb & Sons, L.L.C.
$15
Celgene Corporation
$14
Dova Pharmaceuticals
$14
Top 3 companies account for 43.3% of total payments
Associated products mentioned in payments ›
BESREMI · BOSULIF · DOPTELET · Doptelet · ERLEADA · Kyprolis · LUTATHERA · MEKINIST · Nplate · OPDIVO · REBLOZYL · RYTELO · SARCLISA · Trodelvy · Vonjo · Xermelo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $6 per 100 Medicare services performed
Looking for a hematology & oncology in Abilene?
Compare hematology & oncologys in the Abilene area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
5
Per 100K population
3.5
County median income
$66,406
Nearest hospital
OCEANS BEHAVIORAL HOSPITAL OF ABILENE
8.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Madhira is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Madhira experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Madhira performed 8,160 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Madhira receive payments from pharmaceutical companies?
Yes. Dr. Madhira received a total of $776 from 15 companies across 18 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Madhira's costs compare to other hematology & oncologys in Abilene?
Dr. Madhira's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Madhira) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →